315 related articles for article (PubMed ID: 29224885)
1. Economic optimization of selective dry cow treatment.
Scherpenzeel CGM; Hogeveen H; Maas L; Lam TJGM
J Dairy Sci; 2018 Feb; 101(2):1530-1539. PubMed ID: 29224885
[TBL] [Abstract][Full Text] [Related]
2. Effect of different scenarios for selective dry-cow therapy on udder health, antimicrobial usage, and economics.
Scherpenzeel CGM; den Uijl IEM; van Schaik G; Riekerink RGMO; Hogeveen H; Lam TJGM
J Dairy Sci; 2016 May; 99(5):3753-3764. PubMed ID: 26947289
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic use and potential economic impact of implementing selective dry cow therapy in large US dairies.
Hommels NMC; Ferreira FC; van den Borne BHP; Hogeveen H
J Dairy Sci; 2021 Aug; 104(8):8931-8946. PubMed ID: 33934855
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective dry cow treatment on udder health and antimicrobial usage on Dutch dairy farms.
Tijs SHW; Holstege MMC; Scherpenzeel CGM; Santman-Berends IMGA; Velthuis AGJ; Lam TJGM
J Dairy Sci; 2022 Jun; 105(6):5381-5392. PubMed ID: 35379456
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of selective dry cow treatment following on-farm culture: risk of postcalving intramammary infection and clinical mastitis in the subsequent lactation.
Cameron M; McKenna SL; MacDonald KA; Dohoo IR; Roy JP; Keefe GP
J Dairy Sci; 2014; 97(1):270-84. PubMed ID: 24183691
[TBL] [Abstract][Full Text] [Related]
6. Potential impacts to antibiotics use around the dry period if selective dry cow therapy is adopted by dairy herds: An example of the western US.
Ferreira FC; Martínez-López B; Okello E
Prev Vet Med; 2022 Sep; 206():105709. PubMed ID: 35835049
[TBL] [Abstract][Full Text] [Related]
7. Monitoring udder health on routinely collected census data: Evaluating the short- to mid-term consequences of implementing selective dry cow treatment.
Santman-Berends IMGA; van den Heuvel KWH; Lam TJGM; Scherpenzeel CGM; van Schaik G
J Dairy Sci; 2021 Feb; 104(2):2280-2289. PubMed ID: 33358166
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of udder health parameters and risk factors for clinical mastitis in Dutch dairy herds in the context of a restricted antimicrobial usage policy.
Santman-Berends IMGA; Swinkels JM; Lam TJGM; Keurentjes J; van Schaik G
J Dairy Sci; 2016 Apr; 99(4):2930-2939. PubMed ID: 26874413
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the use of dry cow antibiotics in low somatic cell count cows.
Scherpenzeel CG; den Uijl IE; van Schaik G; Olde Riekerink RG; Keurentjes JM; Lam TJ
J Dairy Sci; 2014; 97(6):3606-14. PubMed ID: 24746132
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial investigating the effect of 2 selective dry-cow therapy protocols on udder health and performance in the subsequent lactation.
Rowe SM; Godden SM; Nydam DV; Gorden PJ; Lago A; Vasquez AK; Royster E; Timmerman J; Thomas MJ
J Dairy Sci; 2020 Jul; 103(7):6493-6503. PubMed ID: 32331877
[TBL] [Abstract][Full Text] [Related]
11. Milk yield and somatic cell count during the following lactation after selective treatment of cows at dry-off.
Rajala-Schultz PJ; Torres AH; Degraves FJ
J Dairy Res; 2011 Nov; 78(4):489-99. PubMed ID: 21939576
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of Austrian health recording data of antibiotic or nonantibiotic dry-off treatment on milk yield, somatic cell count, and frequency of mastitis in subsequent lactation.
Wittek T; Tichy A; Grassauer B; Egger-Danner C
J Dairy Sci; 2018 Feb; 101(2):1456-1463. PubMed ID: 29153520
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for clinical or subclinical mastitis following infusion of internal teat sealant alone at the end of lactation in cows with low somatic cell counts.
McDougall S; Williamson J; Gohary K; Lacy-Hulbert J
N Z Vet J; 2022 Mar; 70(2):79-87. PubMed ID: 34487486
[TBL] [Abstract][Full Text] [Related]
14. Effects of antibiotic dry-cow therapy and internal teat sealant on milk somatic cell counts and clinical and subclinical mastitis in early lactation.
Golder HM; Hodge A; Lean IJ
J Dairy Sci; 2016 Sep; 99(9):7370-7380. PubMed ID: 27320676
[TBL] [Abstract][Full Text] [Related]
15. Invited review: Selective use of antimicrobials in dairy cattle at drying-off.
McCubbin KD; de Jong E; Lam TJGM; Kelton DF; Middleton JR; McDougall S; De Vliegher S; Godden S; Rajala-Schultz PJ; Rowe S; Speksnijder DC; Kastelic JP; Barkema HW
J Dairy Sci; 2022 Sep; 105(9):7161-7189. PubMed ID: 35931474
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of selective dry cow treatment following on-farm culture: Milk yield and somatic cell count in the subsequent lactation.
Cameron M; Keefe GP; Roy JP; Stryhn H; Dohoo IR; McKenna SL
J Dairy Sci; 2015 Apr; 98(4):2427-36. PubMed ID: 25648799
[TBL] [Abstract][Full Text] [Related]
17. Farmers' attitude toward the introduction of selective dry cow therapy.
Scherpenzeel CGM; Tijs SHW; den Uijl IEM; Santman-Berends IMGA; Velthuis AGJ; Lam TJGM
J Dairy Sci; 2016 Oct; 99(10):8259-8266. PubMed ID: 27448856
[TBL] [Abstract][Full Text] [Related]
18. Cow-level risk factors for clinical mastitis in the dry period in cows treated with an internal teat sealant alone at the end of lactation.
McDougall S; Castle R
N Z Vet J; 2021 Nov; 69(6):327-336. PubMed ID: 34061718
[TBL] [Abstract][Full Text] [Related]
19. Infection dynamics across the dry period using Dairy Herd Improvement somatic cell count data and its effect on cow performance in the subsequent lactation.
Lipkens Z; Piepers S; Verbeke J; De Vliegher S
J Dairy Sci; 2019 Jan; 102(1):640-651. PubMed ID: 30415851
[TBL] [Abstract][Full Text] [Related]
20. Management factors associated with the incidence of clinical mastitis over the non-lactation period and bulk tank somatic cell count during the subsequent lactation.
McDougall S
N Z Vet J; 2003 Apr; 51(2):63-72. PubMed ID: 16032302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
